Navigation Links
Dr. Robert J. Rubin to Join Halt Board as Reimbursement Advisor
Date:7/26/2010

LIVERMORE, Calif., July 26 /PRNewswire/ -- Halt Medical, Inc. announced today that Robert J. Rubin, M.D. has been appointed to its Scientific Advisory Board.  Dr. Rubin will also be a consultant to the company, helping to develop and implement comprehensive reimbursement strategies.  Dr. Rubin's distinguished career has included significant contributions in the fields of medicine, government, and business. Currently, he is Clinical Professor of Medicine at Georgetown University's School of Medicine and serves as a consultant to several international healthcare companies. Among his positions in government, Dr. Rubin served as Assistant Secretary, U.S. Department of Health and Human Services (DHHS), concurrent with his appointment as Assistant Surgeon General from 1981 to 1984.  Among his positions in business, Dr. Rubin served as president of the leading healthcare consulting firm, The Lewin Group, Inc., and its predecessor organizations, from 1987 to 2001.

"Dr. Rubin brings to Halt Medical significant medical and business expertise", commented Jeff Cohen, Halt's Chief Executive Officer.  "While Dr. Rubin was at the DHHS, he was responsible for passage of Medicare's Prospective Payment System.  His guidance will add significant value to Halt, particularly in the areas of public and private sector reimbursement strategies for the Halt Fibroid Procedure".  

About Halt Medical, Inc.

Halt Medical, Inc. is a late-stage medical device design and manufacturing company developing products to ablate tissue with its next generation Radiofrequency Volumetric Thermal Ablation (RFVTA) system.  The Halt system has been cleared by the FDA for general use and is currently being studied in the US for relief of symptoms caused by uterine fibroids.  Halt is preparing to commercialize the Halt Fibroid System in Europe where it has recently obtained the CE mark for general and fibroid indications.  The worldwide business opportunity for the Halt Fibroid System is estimated to be over $2 billion annually.  

Information about the Halt Fibroid Study and a list of clinical sites in the U.S. may be found at

www.clinicaltrials.gov, study number NCT00874029.


'/>"/>
SOURCE Halt Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Franco Nuschese Tapped by Robert C. Gallo Foundation for AIDS and Virus Research
2. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
3. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
4. Veridiam Names Robert Mazzacavallo New CFO
5. Wound Management Technologies Completes Acquisition of Secure eHealth, LLC and Other Assets from VirtualHealth Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
6. VirtualHealth Technologies Completes Sale of Secure eHealth, LLC and Other Assets to Wound Management Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
7. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
8. Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo
9. Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases
10. PolyTouch Medical Ltd. Announces the Appointment of Robert D. Fanelli, MD, FACS, FASGE as Medical Advisor
11. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 On Thursday, the NASDAQ Composite ... while the Dow Jones Industrial Average managed to stay in ... markets, which prompted Stock-callers this morning to look at the ... NUVA ), Smith & Nephew PLC (NYSE: ... and Cesca Therapeutics Inc. (NASDAQ: KOOL ). You ...
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... , Dec. 2, 2016 Allergan plc (NYSE: ... provided additional information on its previously announced Accelerated Share Repurchase ... ... As previously announced, the Company entered ... under which the Company will repurchase $10 billion of its ...
Breaking Medicine Technology:
(Date:11/30/2016)... ... November 30, 2016 , ... The Fertility Centers of ... a Cigna Infertility Center of Excellence. The Cigna Center of Excellence recognizes participating ... honor to be designated a Cigna Infertility Center of Excellence," said Fertility Centers ...
(Date:11/30/2016)... , ... November 30, 2016 , ... "I hate when ... arm while brushing my teeth," said an inventor from Bridgewater, N.J. "I thought that ... develop this handy device." , He developed the patent-pending DEFLECTOR to prevent saliva and ...
(Date:11/30/2016)... Palm Beach Gardens, FL (PRWEB) , ... November ... ... leader in eating disorder and mental health treatment has announced the opening of ... facility provides specialized partial hospitalization and intensive outpatient treatment for adults and adolescents, ...
(Date:11/30/2016)... ... November 30, 2016 , ... In ... been a focus of public policymakers and system stakeholders in many states. To ... its Medical Price Index for Workers’ Compensation, Eighth Edition (MPI-WC) . , ...
(Date:11/30/2016)... ... 2016 , ... The Clinical Data Interchange Standards Consortium (CDISC) ... goes into effect next month. Sponsors whose studies start after December 17, 2016 ... The current FDA Data Standards Catalog specifies the use of CDISC standards: ...
Breaking Medicine News(10 mins):